[Drug monitoring in intensive care].

Drug interactions with cimetidine. Clin Pharmacokinet (1982) 2.49

Impaired cimetidine absorption due to antacids and metoclopramide. Eur J Clin Pharmacol (1981) 1.86

Automated gas chromatography for studies of midazolam pharmacokinetics. Anesthesiology (1981) 1.78

Clinical pharmacokinetics of quinidine. Clin Pharmacokinet (1980) 1.59

Pharmacokinetics of pindolol in man. Eur J Clin Pharmacol (1974) 1.46

Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med (1980) 1.42

Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet (1980) 1.42

Is radical scavenging necessary in the treatment of inflammatory bowel disease? Gastroenterology (1991) 1.39

[The duodenojejunal flexure--a gap in the routine diagnosis of gastrointestinal bleeding]. Dtsch Med Wochenschr (1999) 1.38

The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man. Clin Pharmacol Ther (1975) 1.33

Clinical pharmacokinetics of cimetidine. Clin Pharmacokinet (1984) 1.32

Cimetidine for anastomotic ulcers after partial gastrectomy. A randomized controlled trial. N Engl J Med (1979) 1.32

Cimetidine plasma concentration-response relationships. Clin Pharmacol Ther (1981) 1.29

Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro. Gastroenterology (1985) 1.29

Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. Gut (1982) 1.22

Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol (1975) 1.21

Phenytoin: pharmacokinetics and bioavailability. Clin Pharmacol Ther (1976) 1.14

Single- and multiple-dose metronidazole kinetics. Clin Pharmacol Ther (1983) 1.09

Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease. Br J Clin Pharmacol (1978) 1.08

Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis. Diabetes Care (2001) 1.07

Inhibition of human liver cytochrome P-450 by omeprazole. Br J Clin Pharmacol (1986) 1.06

Spironolactone. Am Heart J (1978) 1.05

Pharmacokinetics of ketamine in man. Anaesthesist (1975) 1.03

Effect of in vivo elevation of free fatty acids on protein binding of drugs. Pharmacology (1974) 1.02

Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet (1980) 1.02

Effect of propranolol on pharmacokinetics and acute electrocardiographic changes following intravenous quinidine in humans. Pharmacology (1978) 1.02

Diazepam interaction with antituberculosis drugs. Clin Pharmacol Ther (1981) 0.99

Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women. Clin Pharmacokinet (1989) 0.98

Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabet Med (2004) 0.98

HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet (2005) 0.98

Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man? Gut (1987) 0.97

Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration. J Pharmacol Exp Ther (1977) 0.97

Disposition of oxazepam in relation to age, sex, and cigarette smoking. Klin Wochenschr (1981) 0.97

Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet (1983) 0.97

Clofibrate disposition in renal failure and acute and chronic liver disease. Eur J Clin Pharmacol (1979) 0.95

Nifedipine: kinetics and dynamics after single oral doses. Klin Wochenschr (1984) 0.94

Effect of portacaval shunt on the disposition of drugs with and without first-pass effect. J Pharmacol Exp Ther (1975) 0.94

Propranolol interactions with diazepam, lorazepam, and alprazolam. Clin Pharmacol Ther (1984) 0.94

Potentially toxic serum lidocaine concentrations following spray anesthesia for bronchoscopy. Klin Wochenschr (1983) 0.94

Single- and multiple-dose kinetics of intravenous digoxin. Clin Pharmacol Ther (1980) 0.93

Drug protein binding and the nephrotic syndrome. Clin Pharmacokinet (1976) 0.92

Pharmacokinetics of drugs in patients with the nephrotic syndrome. J Clin Invest (1975) 0.92

Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives. Clin Pharmacol Ther (1983) 0.91

Reduced quinidine clearance in elderly persons. Am J Cardiol (1978) 0.91

Influence of thyroid status on plasma half-life of antipyrine in man. N Engl J Med (1974) 0.90

Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: relation to lipid solubility. J Pharm Pharmacol (1985) 0.90

Omeprazole inhibits elimination of diazepam. Lancet (1984) 0.90

Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs. Br J Clin Pharmacol (1980) 0.90

Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data. Eur J Clin Pharmacol (1982) 0.90

Clofibrate kinetics after single and multiple doses. Clin Pharmacol Ther (1978) 0.89

Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics. Drug Metab Rev (1983) 0.88

In vivo interactions between H2-receptor antagonists and ethanol metabolism in man and in rats. Hepatology (1985) 0.88

Increased metabolic clearance of acetaminophen with oral contraceptive use. Obstet Gynecol (1982) 0.88

[Familial dwarfism with disproportionately high vertebral bodies]. Humangenetik (1972) 0.87

Effect of clofibrate on the metabolism of bilirubin, bromosulphophthalein and indocyanine green and on the biliary lipid composition in Gilbert's syndrome. Clin Sci (Lond) (1984) 0.87

Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension. Eur J Clin Pharmacol (1984) 0.87

Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation. Pharmacology (1984) 0.87

Impairment of digoxin clearance by coadministration of quinidine. J Clin Pharmacol (1981) 0.87

Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450. Biochem Pharmacol (1985) 0.86

Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration. Arzneimittelforschung (1982) 0.86

Dose-independent pharmacokinetics of digoxin in humans. Am Heart J (1978) 0.86

Disposition of valproic acid in man. Eur J Clin Pharmacol (1977) 0.85

Interaction of ibuprofen with the H-2 receptor antagonists ranitidine and cimetidine. Clin Pharmacol Ther (1985) 0.85

Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids. N Engl J Med (1982) 0.84

Reversal of inotropic effects of digoxin by specific antibodies and their Fab fragments in the conscious dog. J Pharmacol Exp Ther (1978) 0.84

[Purification and characterization of a 3'-phosphoadenylylsulfate: steroid sulfotransferase from human liver]. Biochim Biophys Acta (1970) 0.83

Drugs other than H2-receptor antagonists as clinically important inhibitors of drug metabolism in vivo. Pharmacol Ther (1987) 0.83

Gastric acid inhibition and oxmetidine kinetics in duodenal ulcer. Clin Pharmacol Ther (1982) 0.83

Single and multiple dose pharmacokinetics of pindolol. Eur J Clin Pharmacol (1978) 0.83

Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation. Br J Clin Pharmacol (1983) 0.83

Age, sex, and nitrazepam kinetics: relation to antipyrine disposition. Clin Pharmacol Ther (1985) 0.83

Noninteraction of digitoxin and quinidine. N Engl J Med (1980) 0.83

Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments. J Clin Invest (1977) 0.83

Effect of penbutolol on lidocaine kinetics. Arzneimittelforschung (1983) 0.83

Sensitive high-performance liquid chromatographic method for the determination of metronidazole and metabolites. J Chromatogr (1983) 0.82

[Drugs interacting with coumarine oral anticoagulants (author's transl)]. Klin Wochenschr (1973) 0.82

Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg (1983) 0.82

Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans. Am Heart J (1980) 0.82

Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection. J Viral Hepat (2004) 0.82

Kinetics of diazepam, midazolam, and lorazepam in cigarette smokers. Chest (1985) 0.82

Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition. Pharmacology (1989) 0.82

Repeated diazepam dosing in cirrhotic patients: cumulation and sedation. Clin Pharmacol Ther (1983) 0.82

Superoxide inhibition following different stimuli of respiratory burst and metabolism of aminosalicylates in neutrophils. Dig Dis Sci (1994) 0.82

Effect of cimetidine on digoxin kinetics and creatinine clearance. Am Heart J (1984) 0.82

Reduced systemic absorption of intrabronchial lidocaine by high-frequency nebulization. J Clin Pharmacol (1990) 0.81

Entry of diazepam and its major matabolite into cerebrospinal fluid. Psychopharmacology (Berl) (1980) 0.81

Pharmacokinetics of oxaprozin in women receiving conjugated estrogen. Eur J Clin Pharmacol (1988) 0.81

Diphenylhydantoin: correlation between protein binding and albumin concentration. Klin Wochenschr (1975) 0.81

Baroreflex and vagal mechanisms modulating left ventricular contractile responses to sympathomimetic amines in conscious dogs. Circ Res (1979) 0.81

Diazepam kinetics in patients with renal insufficiency or hyperthyroidism. Br J Clin Pharmacol (1981) 0.81

Ultrasound-guided emergency endoscopic retrograde biliary drainage without radiography. Endoscopy (1997) 0.81

Single and multiple dose kinetics of clobazam, and clinical effects during multiple dosage. Eur J Clin Pharmacol (1984) 0.81

Serum-cholesterol-lowering effect of metronidazole and possible mechanisms of action. Klin Wochenschr (1985) 0.80

Entry of quinidine into cerebrospinal fluid. Am Heart J (1980) 0.80

Effect of age and Billroth gastrectomy on absorption of desmethyldiazepam from clorazepate. Clin Pharmacol Ther (1979) 0.80

Diazepam kinetics in relation to age and sex. Pharmacology (1981) 0.79

Analysis of DNA strand breaks, oxidized bases, and glutathione S-transferase P1 in human colon cells from biopsies. Cancer Epidemiol Biomarkers Prev (1999) 0.79

Dose-independent pharmacokinetics of intravenous lidocaine in humans. J Clin Pharmacol (1983) 0.79

Is temazepam an accumulating hypnotic? J Clin Pharmacol (1984) 0.79